Cargando…
Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers
BACKGROUND: One of the most common causes of morbidity and mortality in children with sickle cell disease (SCD) is infection with the pneumococcal bacterium (Streptococcus pneumoniae). Unfortunately, the polysaccharide-conjugate vaccine appears to be less effective in individuals with SCD when compa...
Autores principales: | Szczepanek, Steven M., Roberts, Sean, Rogers, Kara, Cotte, Christina, Adami, Alexander J., Bracken, Sonali J., Salmon, Sharon, Secor, Eric R., Thrall, Roger S., Andemariam, Biree, Metzger, Dennis W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766082/ https://www.ncbi.nlm.nih.gov/pubmed/26910228 http://dx.doi.org/10.1371/journal.pone.0149261 |
Ejemplares similares
-
Transgenic sickle cell disease mice have high mortality and dysregulated immune responses after vaccination
por: Szczepanek, Steven M., et al.
Publicado: (2013) -
Mathematical Modelling Long-Term Effects of Replacing Prevnar7 with Prevnar13 on Invasive Pneumococcal Diseases in England and Wales
por: Choi, Yoon Hong, et al.
Publicado: (2012) -
Valsartan impedes epinephrine-induced ICAM-4 activation on normal, sickle cell trait and sickle cell disease red blood cells
por: Zhang, Jing, et al.
Publicado: (2019) -
Patient Controlled Analgesia for Adults with Sickle Cell Disease Awaiting Admission from the Emergency Department
por: Santos, Josue, et al.
Publicado: (2016) -
A recombinant conjugated pneumococcal vaccine that protects against murine infections with a similar efficacy to Prevnar-13
por: Reglinski, Mark, et al.
Publicado: (2018)